Literature DB >> 21296144

Anti-inflammatory effects of Huang-Lian-Jie-Du decoction, its two fractions and four typical compounds.

Juan Lu1, Jun-Song Wang, Ling-Yi Kong.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Huang-Lian-Jie-Du decoction (HLJDD) (Oren-gedoku-to in Japanese) as a famous traditional Chinese recipe is composed of Rhizoma coptidis, Radix scutellariae, Cortex phellodendri and Fructus gardeniae. It has been used to treat inflammation for nearly two thousand years. AIM OF THE STUDY: To explore the material base for the anti-inflammatory activity of formula HLJDD, its extract was fractionated on D101 macroporous resin to afford two fractions, HLJDD-1 and HLJDD-2. The whole formula, HLJDD-1 and HLJDD-2, and four typical component compounds were then evaluated for their effects on inflammation-related parameters using lipopolysaccharide (LPS)-induced RAW264.7 cells as a model system.
MATERIALS AND METHODS: The effect of HLJDD on carrageenan-induced mice paw edema was first evaluated. A series of inflammation-related parameters including malondialdehyde (MDA), nitric oxide (NO), superoxide dismutase (SOD), prostaglandin E(2) (PGE2), tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6) and interleukin-10 (IL-10) were then measured in LPS-induced RAW264.7 cells treated with HLJDD, its two fractions, and four typical component compounds (geniposide, baicalin, berberine and baicalein).
RESULTS: With the help of principal component analysis (PCA) technique, the data obtained revealed that the two fractions and the major group of compounds in HLJDD (iridoids, flavonoids and alkaloids) complement each other with particular emphasis to synergistically exert anti-inflammatory effects.
CONCLUSIONS: This study demonstrated that HLJDD exhibited anti-inflammatory effect as a "whole", which justified the combined use of the four component herbs forming the compound prescription and suggested quality control of HLJDD based on its three types of components. Crown
Copyright © 2011. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21296144     DOI: 10.1016/j.jep.2011.01.049

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  37 in total

1.  Quantitative analysis of anti-inflammatory activity of orengedokuto: importance of combination of flavonoids in inhibition of PGE2 production in mouse macrophage-like cell line J774.1.

Authors:  Naohiro Oshima; Yuji Narukawa; Noriyasu Hada; Fumiyuki Kiuchi
Journal:  J Nat Med       Date:  2012-06-23       Impact factor: 2.343

2.  Protection of long-term treatment with huang-lian-jie-du-tang on vascular endothelium in rats with type 2 diabetes mellitus.

Authors:  Quan Yi; Xiao-En He; Kai-Fey Luo; Gen-Shui Zhang; Ying-Hua Liu; Qin Xue; Ning Hou; Wen-Liang Chen; Jian-Dong Luo
Journal:  Curr Ther Res Clin Exp       Date:  2012-12

3.  Quantitative analysis of the anti-inflammatory activity of orengedokuto II: berberine is responsible for the inhibition of NO production.

Authors:  Naohiro Oshima; Tomofumi Shimizu; Yuji Narukawa; Noriyasu Hada; Fumiyuki Kiuchi
Journal:  J Nat Med       Date:  2018-04-18       Impact factor: 2.343

4.  Novel quercetin-3-O-glucoside eicosapentaenoic acid ester ameliorates inflammation and hyperlipidemia.

Authors:  Satvir Sekhon-Loodu; Ziaullah Ziaullah; H P Vasantha Rupasinghe; Yanwen Wang; Marianna Kulka; Fereidoon Shahidi
Journal:  Inflammopharmacology       Date:  2015-07-14       Impact factor: 4.473

5.  Anti-inflammatory effects of extracellular vesicles from Morchella on LPS-stimulated RAW264.7 cells via the ROS-mediated p38 MAPK signaling pathway.

Authors:  Qi Chen; Chengchuan Che; Shanshan Yang; Pingping Ding; Meiru Si; Ge Yang
Journal:  Mol Cell Biochem       Date:  2022-07-07       Impact factor: 3.396

6.  Fever of unknown origin successfully treated by oren-gedoku-to (huanglian-jie-du-tang).

Authors:  Koichiro Tanaka; Kazuhiko Nara; Tetsuya Nishimura; Keiko Serizawa; Taito Miyazaki; Yoshihisa Urita; Oto Miura
Journal:  Int J Gen Med       Date:  2013-10-07

7.  Combination of ¹H NMR- and GC-MS-based metabonomics to study on the toxicity of Coptidis Rhizome in rats.

Authors:  Yuting Zhou; Qiongfeng Liao; Manna Lin; Xuejiao Deng; Peiting Zhang; Meicun Yao; Lei Zhang; Zhiyong Xie
Journal:  PLoS One       Date:  2014-02-05       Impact factor: 3.240

8.  Simultaneous quantification and antiatherosclerosis effect of the traditional Korean medicine, Hwangryunhaedok-tang.

Authors:  Chang-Seob Seo; Ohn Soon Kim; Jung-Hoon Kim; Hyeun-Kyoo Shin
Journal:  BMC Complement Altern Med       Date:  2015-04-08       Impact factor: 3.659

9.  Therapeutic effect of Jinzhen oral liquid for hand foot and mouth disease: a randomized, multi-center, double-blind, placebo-controlled trial.

Authors:  Jun Liu; Guo-Liang Zhang; Gui-Qin Huang; Li Li; Chun-Ping Li; Mei Wang; Xiao-Yan Liang; Di Xie; Chang-Ming Yang; Yan Li; Xiu-Rong Sun; Hong-Sen Zhang; Bai-Song Wan; Wei-Hua Zhang; Hao Yu; Ru-Yang Zhang; Ya-Nan Yu; Zhong Wang; Yong-Yan Wang
Journal:  PLoS One       Date:  2014-04-10       Impact factor: 3.240

10.  Protective Effects of Huang-Lian-Jie-Du-Tang against Polymicrobial Sepsis Induced by Cecal Ligation and Puncture in Rats.

Authors:  Yufen Wei; Lei Shan; Liming Qiao; Runhui Liu; Zhenlin Hu; Weidong Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2013-12-04       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.